Boehringer Ingelheim USA
President and CEO Dr. Wolfgang Baiker
Senior VP, HR and Communications Jamie Eden
• In 2017, the pharmaceutical company expanded maternity benefits and a paid-parental-leave policy, providing employees with 10 weeks’ maternity leave dependent on delivery, and up to two consecutive weeks of paid leave to bond with their newborn/newly adopted child.
• In 2017, the adoption subsidy was increased from $3,000 to $10,000, and a surrogacy reimbursement was added.